To access this element change to forms mode OFF
Grant Award View - GA24656
Developing novel therapies for cardiac ischaemia reperfusion injury with...
GA ID:
GA24656
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
16-Jul-2018
Publish Date:
6-Nov-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$383,320.32
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Early Career Fellowships
Grant Activity:
Developing novel therapies for cardiac ischaemia reperfusion injury with anti-thrombotic/anti-inflammatory nanoparticles
Purpose:
Heart attack is one of the leading causes of death in Australia. Heart attacks are caused by blockages of the blood vessels in the heart. Developing new treatments that can effectively treat blocked blood vessels are important to improving outcomes for patients with heart attack. This project aims to develop new treatments that can treat and prevent blood vessels from becoming blocked in patients with a heart attack.
GO ID:
GO Title:
NHMRC Early Career Fellowship for Funding 2019
Internal Reference ID:
GNT1161499
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Baker Heart and Diabetes Institute
Recipient ABN:
98 131 762 948
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3004
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA